Orbimed Advisors

Investment Context

This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.

OrbiMed is a broad-based healthcare investor with a global footprint, active across private equity, public equity, and royalty/credit strategies. The firm describes itself as investing from start-ups through growth equity and also across publicly traded healthcare companies worldwide, so its orientation is toward scalable healthcare innovation rather than a narrow thematic mandate. In the psychedelic space, that suggests potential relevance for drug-development companies or later-stage healthcare assets, but there is no public indication of a dedicated psychedelic focus.